Endobarrier treatment for longstanding type 2 diabetes and obesity: Outcomes one-year after endobarrier in 90 consecutively treated patients

被引：0
|
作者：
Ryder, R. E. J. [1 ]
Sen Gupta, P. [2 ,3 ]
Burbridge, W. [1 ]
Irwin, S. P. [1 ]
Bashir, T. [4 ]
Allden, R. A. [5 ]
Bleasdale, J. P. [6 ]
Fogden, E. N. [5 ]
Anderson, M. R. [5 ]
Yadagiri, M. [1 ]
机构：
[1] City Hosp, Diabet, Birmingham, W Midlands, England
[2] Guys Hosp, Diabet, London, England
[3] St Thomas Hosp, Diabet, London, England
[4] City Hosp, Dietet, Birmingham, W Midlands, England
[5] City Hosp, Gastroenterol, Birmingham, W Midlands, England
[6] City Hosp, Anaesthet, Birmingham, W Midlands, England
来源：
DIABETIC MEDICINE | 2021年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P222
引用
收藏
页数：1
相关论文
共 50 条
  • [21] The impact of EndoBarrier gastrointestinal liner in obese patients with normal glucose tolerance and in patients with type 2 diabetes
    Rohde, Ulrich
    Federspiel, Cecilie A.
    Vilmann, Peter
    Langholz, Ebbe
    Friis, Steffen U.
    Krakauer, Martin
    Rehfeld, Jens F.
    Holst, Jens J.
    Vilsboll, Tina
    Knop, Filip K.
    DIABETES OBESITY & METABOLISM, 2017, 19 (02): : 189 - 199
  • [22] Duodenal jejunal bypass liner (DJBL) for treatment of type 2 diabetes and obesity: risks and benefits among 926 patients in the worldwide EndoBarrier (EB) registry
    Ryder, R. E. J.
    Sen Gupta, P.
    Stengel, R.
    Mitchell, K.
    Drummond, R.
    Frydenberg, H.
    Munro, L.
    Fishman, S.
    Cohen, R.
    de Jonge, C.
    Greve, J.
    Benes, M.
    Aberle, J.
    Laubner, K.
    Seufert, J.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 298 - 298
  • [23] Satiety Hormone LEAP2 After Low-Calorie Diet With/Without Endobarrier Insertion in Obesity and Type 2 Diabetes Mellitus
    Emini, Mimoza
    Bhargava, Raghav
    Aldhwayan, Madhawi
    Chhina, Navpreet
    Flores, Marcela Rodriguez
    Aldubaikhi, Ghadah
    Al Lababidi, Moaz
    Al-Najim, Werd
    Miras, Alexander D.
    Ruban, Aruchuna
    Glaysher, Michael A.
    Prechtl, Christina G.
    Byrne, James P.
    Teare, Julian P.
    Goldstone, Anthony P.
    JOURNAL OF THE ENDOCRINE SOCIETY, 2024, 9 (01)
  • [24] WEIGHT LOSS AND METABOLIC IMPROVEMENTS ONE YEAR AFTER TREATMENT WITH A DUODENAL-JEJUNAL BYPASS SLEEVE (ENDOBARRIER®)
    McMaster, Jessica J.
    Shanahan, Erin R.
    Anh Do
    Rich, Graeme
    Veronique, Chachay
    Macdonald, Graeme A.
    Holtmann, Gerald J.
    GASTROENTEROLOGY, 2019, 156 (06) : S1170 - S1171
  • [25] Duodenal Jejunal Bypass Liner (DJBL) for treatment of type 2 diabetes and obesity: the risk benefit ratio from the worldwide EndoBarrier (EB) registry in 871 patients
    Laubner, K.
    Seufert, J.
    Aberle, J.
    Frydenberg, H.
    Munro, L.
    Fishman, S.
    Cohen, R.
    Holtmann, G.
    de Jonge, C.
    Greve, J.
    Kow, L.
    Bessell, J.
    Sourij, H.
    Benes, M.
    Ryder, R. E. J.
    DIABETOLOGIA, 2019, 62 : S390 - S390
  • [26] Endobarrier® gastrointestinal liner in obese subjects with type 2 diabetes - Sustainable effects on insulin sensitivity after explantation
    Pferschy, Peter
    Tripolt, Norbert
    Url, Jasmin
    Aberer, Felix
    Hoegenauer, Christoph
    Schreiber, Florian
    Eherer, Andreas
    Sourij, Caren
    Svehlikova, Eva
    Obermayer, Anna-Maria
    Stadlbauer, Vanessa
    Sourij, Harald
    WIENER KLINISCHE WOCHENSCHRIFT, 2018, 130 : 374 - 374
  • [27] Outcomes of four patients with osteonecrosis after one-year pamidronate treatment
    Acinikli, Kubra Yuksek
    Besci, Ozge
    Yasar, Elif
    Tufekci, Ozlem
    Karadag, Zehra
    Yildiz, Gizem
    Torun, Ruya
    Kagizmanli, Gozde Akin
    Bayram, Meral Torun
    Yilmaz, Sebnem
    Guleryuz, Handan
    Abaci, Ayhan
    Bober, Ece
    Demir, Korcan
    HORMONE RESEARCH IN PAEDIATRICS, 2022, 95 (SUPPL 2): : 144 - 145
  • [28] WHAT HAPPENS TO OVERWEIGHT AND TYPE 2 DIABETES AFTER EXPLANTATION OF THE ENDOBARRIER/DUODENAL-JEJUNAL BYPASS LINER?
    Betzel, B.
    Koehestanie, P.
    Aarts, E.
    Homan, J.
    Dogan, K.
    Wahab, P.
    Groenen, M.
    Janssen, I.
    Berends, F.
    OBESITY SURGERY, 2014, 24 (08) : 1309 - 1309
  • [29] The duodenal-jejunal bypass sleeve (EndoBarrier Gastrointestinal Liner) for weight loss and treatment of type 2 diabetes
    Patel, Shaneel R. H.
    Hakim, David
    Mason, John
    Hakim, Nadey
    SURGERY FOR OBESITY AND RELATED DISEASES, 2013, 9 (03) : 482 - 484
  • [30] One-year efficacy and safety of IDegLira in patients with type 2 diabetes
    Gough, S. C. L.
    Buse, J. B.
    Woo, V. C.
    Rodbard, H. W.
    Linjawi, S.
    Poulsen, P.
    Korsholm, L.
    Bode, B. W.
    DIABETOLOGIA, 2014, 57 : S39 - S39
12345